A5001846078- Acute Ischemic Stroke Management
- Venous Thromboembolism Diagnosis and Management
- Inflammatory Biomarkers in Disease Prognosis
- Autoimmune Neurological Disorders and Treatments
- Cardiac Arrest and Resuscitation
- RNA regulation and disease
- Respiratory Support and Mechanisms
- Mechanical Circulatory Support Devices
- Atrial Fibrillation Management and Outcomes
- Peripheral Neuropathies and Disorders
Marmara University
2024
Sağlık Bilimleri Üniversitesi
2020-2022
Fatih Sultan Mehmet Eğitim Ve Araştırma Hastanesi
2020-2022
Objective: To evaluate the effect of mean platelet volume (MPV), on short-term prognosis and bleeding complications acute ischemic stroke patients who underwent intravenous tissue plasminogen activator (IV-tPA) treatment. Patients Methods: Between 01.01.2018 01.06.2021, 314 applied to our clinic with neurological deficit were included in study retrospectively. Alteplase was administered as IV-tPA treatment for 1 hour. MPV value measured before evaluated main parameter. The examined under 4...
Herein, we report two acute ischemic stroke cases that used prothrombin complex to reverse the effects of warfarin in order apply intravenous thrombolytic treatment. To best our knowledge, there are only limited amount concentrates were applied prior treatment administration. As one biggest clinics country, aim open a discussion for this be fully researched and understood.